• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾部分切除术(NSS)与经皮热消融术(TA)治疗cT1期肾癌的疗效比较。

Comparison of the Results of Therapy for cT1 Renal Carcinoma with Nephron-Sparing Surgery (NSS) vs. Percutaneous Thermal Ablation (TA).

作者信息

Rusinek Michał, Salagierski Marek, Różański Waldemar, Jakóbczyk Bartłomiej, Markowski Michał, Lipiński Marek, Wilkosz Jacek

机构信息

IInd Department of Urology, Medical University of Lodz, al. Kościuszki 4, 90-419 Łódź, Poland.

出版信息

J Pers Med. 2022 Mar 18;12(3):495. doi: 10.3390/jpm12030495.

DOI:10.3390/jpm12030495
PMID:35330494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8956074/
Abstract

UNLABELLED

Implementation of ultrasonography (USG), computed tomography (CT) and magnetic resonance imaging (MRI) into abdominal cavity diagnostics enabled early detection of cT1 graded renal cancers. According to European Association of Urology (EAU) and Polish urological Association (PUA) recommended method of treatment is sparing resection of renal parenchyma with tumour-nephron-sparing surgery (NSS). In selected cases other methods such as thermal ablation (TA) or cryoablation can be introduced /1/.

OBJECTIVES

To evaluate the results of treatment of cT1 renal tumours with the use of NSS and TA methods.

MATERIAL AND METHODS

140 patients with cT1 renal carcinoma were treated in 2nd Department of Urology of Medical University of Lodz between 2014 and 2017. Neuron-sparing surgery was performed in 56 cases (40%), while percutane-ous thermal ablation (TA) in 84 cases (60%). Demographic data, clinical data (lab results, Charlson index), nephrometry data (tumour size, location, R.E.N.A.L. score) post-operative data (Clavien-Dindo classifica-tion) were investigated. Histopathology results, Fuhrman malignancy grading, as total three-year survival of patients were evaluated. The following methods were used for statistical evaluation: Chi2, Fisher, W Shapiro-Wilk, U Mann-Whitney tests, Kaplan-Meier's curve and Cox model. The results were displayed in a form of median and upper and lower quartile values (25-75%).

RESULTS

No statistical differences in gender nor left/right kidney location were observed. Patients, who underwent TA were at average 10 years older and had multiple comorbidities (median age for TA was 79, for NSS 68; median Charlson index for TA was 5 and for NSS was 3). TA patients had lesser haematological values (Hb, Ht). R.E.N.A.L. scoring demonstrated comparable nephrometry in both groups. NSS procedure was open laparotomy without temporary clamping of renal vessels. Surgical margins of resected tumours were negative. TA was performed with Cool-Tip Covidienequipment with the use of Cluster electrode and was ultraso-nography-guided. Post-treatment complications evaluated with the use of Clavien-Dindo classification were slightly more frequent for NSS method. Patients after NSS were discharged at average after 8.5 days and after TA after 3 days. Histopathological type and Fuhrman malignancy grading were comparable in both groups. TA treated patients' death risk was 9-fold of that observed in NSS treated patients. There was 1 death for each group in perioperative period.

CONCLUSION

  1. NSS was associated with slightly higher side effect rate but resulted in prolonged survival. 2. TA was applied to elderly patients with comorbidities. Despite less invasive treatment this group had poorer/reduced survival. 3. Charlson Comorbidity Index (CCI) and the treatment method were relevant survival factors in patients treated due to cT1 renal cancer tumours.
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e0/8956074/a7198f449402/jpm-12-00495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e0/8956074/7c7291fc2cbc/jpm-12-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e0/8956074/a7198f449402/jpm-12-00495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e0/8956074/7c7291fc2cbc/jpm-12-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e0/8956074/a7198f449402/jpm-12-00495-g002.jpg
摘要

未标注

将超声检查(USG)、计算机断层扫描(CT)和磁共振成像(MRI)应用于腹腔诊断能够早期发现cT1级肾癌。根据欧洲泌尿外科学会(EAU)和波兰泌尿外科学会(PUA)的建议,治疗方法是采用保留肾单位手术(NSS)对肾实质进行保留肿瘤的切除术。在某些特定情况下,可采用其他方法,如热消融(TA)或冷冻消融 /1/。

目的

评估使用NSS和TA方法治疗cT1期肾肿瘤的效果。

材料与方法

2014年至2017年期间,罗兹医科大学第二泌尿外科对140例cT1期肾癌患者进行了治疗。其中56例(40%)接受了保留肾单位手术,84例(60%)接受了经皮热消融(TA)。研究了人口统计学数据、临床数据(实验室检查结果、查尔森指数)、肾计量学数据(肿瘤大小、位置、R.E.N.A.L.评分)、术后数据(Clavien-Dindo分级)。评估了组织病理学结果、富尔曼恶性分级以及患者的三年总生存率。采用以下统计评估方法:卡方检验、费舍尔检验、W夏皮罗-威尔克检验、U曼-惠特尼检验、卡普兰-迈耶曲线和考克斯模型。结果以中位数以及上下四分位数(25 - 75%)的形式呈现。

结果

在性别以及左右肾位置方面未观察到统计学差异。接受TA治疗的患者平均年龄大10岁且有多种合并症(TA组的中位年龄为79岁,NSS组为68岁;TA组的中位查尔森指数为5,NSS组为3)。TA组患者的血液学指标(血红蛋白、血细胞比容)较低。R.E.N.A.L.评分显示两组的肾计量学情况相当。NSS手术采用开放性剖腹术,未临时夹闭肾血管。切除肿瘤的手术切缘为阴性。TA采用柯惠Cool-Tip设备,使用集束电极,并在超声引导下进行。使用Clavien-Dindo分级评估的治疗后并发症在NSS组稍多。NSS组患者平均8.5天后出院,TA组患者平均3天后出院。两组的组织病理学类型和富尔曼恶性分级相当。TA治疗患者的死亡风险是NSS治疗患者的9倍。围手术期每组各有1例死亡。

结论

  1. NSS的副作用发生率略高,但能延长生存期。2. TA适用于有合并症的老年患者。尽管该治疗侵入性较小,但该组患者的生存期较差/缩短。3. 查尔森合并症指数(CCI)和治疗方法是因cT1期肾肿瘤接受治疗患者的相关生存因素。

相似文献

1
Comparison of the Results of Therapy for cT1 Renal Carcinoma with Nephron-Sparing Surgery (NSS) vs. Percutaneous Thermal Ablation (TA).肾部分切除术(NSS)与经皮热消融术(TA)治疗cT1期肾癌的疗效比较。
J Pers Med. 2022 Mar 18;12(3):495. doi: 10.3390/jpm12030495.
2
Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit.全国范围内的保留肾单位手术——英国泌尿外科医师协会2012年全国性部分肾切除术审计结果
BJU Int. 2016 Jun;117(6):874-82. doi: 10.1111/bju.13353. Epub 2015 Nov 18.
3
Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancer.评估RENAL肾计量评分系统在cT1期肾癌保留肾单位手术中的应用
Urol Int. 2013;90(2):179-83. doi: 10.1159/000342971. Epub 2012 Nov 7.
4
Trends in the use of of nephron-sparing surgery (NSS) at an Australian tertiary referral centre: an analysis of surgical decision-making using the R.E.N.A.L. nephrometry scoring system.澳大利亚一家三级转诊中心保肾手术(NSS)使用趋势:应用 R.E.N.A.L. 肾脏解剖评分系统分析手术决策。
BJU Int. 2012 May;109(9):1341-4. doi: 10.1111/j.1464-410X.2011.10595.x. Epub 2011 Sep 27.
5
Frailty predicts outcome of partial nephrectomy and guides treatment decision towards active surveillance and tumor ablation.衰弱预测部分肾切除术的结果,并指导治疗决策向主动监测和肿瘤消融倾斜。
World J Urol. 2021 Aug;39(8):2843-2851. doi: 10.1007/s00345-020-03556-7. Epub 2021 Jan 30.
6
Functional, oncological outcomes and safety of nephron-sparing surgery versus radical nephrectomy in patients with localised renal cell carcinoma with high anatomical complexity: a retrospective cohort study with propensity score matching method.高解剖复杂性局限性肾细胞癌患者行保留肾单位手术与根治性肾切除术的功能、肿瘤学结局和安全性:倾向评分匹配法回顾性队列研究。
BMJ Open. 2021 Dec 24;11(12):e051622. doi: 10.1136/bmjopen-2021-051622.
7
Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm.功能性分析:选择性保肾手术与根治性肾切除术治疗大于 4 厘米的肾肿瘤。
Urology. 2012 Mar;79(3):607-13. doi: 10.1016/j.urology.2011.10.073.
8
Laparoscopic Radiofrequency Ablation Combined with Surgical Excision for Exophytic Renal Angiomyolipoma: A Novel Technique Based on Tumor Vasculature Features of Enhancing Renal Masses Toward Hilar Off-Clamping Nephron-Sparing Surgery.腹腔镜射频消融联合手术切除治疗外生性肾血管平滑肌脂肪瘤:一种基于增强肾肿块向肾门非阻断性保留肾单位手术肿瘤血管特征的新技术。
J Laparoendosc Adv Surg Tech A. 2017 Aug;27(8):823-828. doi: 10.1089/lap.2016.0348. Epub 2016 Nov 2.
9
[Augmented reality for image guided therapy (ARIGT) of kidney tumor during nephron sparing surgery (NSS): animal model and clinical approach].肾部分切除术(NSS)中用于肾肿瘤图像引导治疗(ARIGT)的增强现实技术:动物模型与临床方法
Folia Med Cracov. 2011;51(1-4):77-90.
10
Partial nephrectomy in two patients with known T3a tumours involving the renal vein.两名 T3a 期肿瘤累及肾静脉的患者行部分肾切除术。
BJU Int. 2012 May;109(9):1345-8. doi: 10.1111/j.1464-410X.2011.10477.x. Epub 2011 Aug 24.

引用本文的文献

1
Combining Transarterial Embolization and Percutaneous Cryoablation for Early-Stage Renal Cell Carcinoma: Embolization Materials and Impacts of Tumor Size.经动脉栓塞联合经皮冷冻消融治疗早期肾细胞癌:栓塞材料与肿瘤大小的影响。
Tomography. 2024 Nov 7;10(11):1767-1779. doi: 10.3390/tomography10110130.
2
Perioperative and Oncological Outcomes of Percutaneous Radiofrequency Ablation versus Partial Nephrectomy for cT1a Renal Cancers: A Retrospective Study on Groups with Similar Clinical Characteristics.经皮射频消融术与部分肾切除术治疗cT1a期肾癌的围手术期及肿瘤学结局:对具有相似临床特征的组群进行的回顾性研究
Cancers (Basel). 2024 Apr 17;16(8):1528. doi: 10.3390/cancers16081528.
3

本文引用的文献

1
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel.局限性:现有研究限制了对局部肾肿块患者肿瘤消融术与部分肾切除术的可靠比较:来自欧洲泌尿外科学会肾癌指南小组的系统评价。
Eur Urol Oncol. 2020 Aug;3(4):433-452. doi: 10.1016/j.euo.2020.02.001. Epub 2020 Mar 31.
2
Utilization of Stereotactic Ablative Body Radiation Therapy for Intact Renal Cell Carcinoma: Trends in Treatment and Predictors of Outcome.立体定向消融体部放射治疗在完整肾细胞癌中的应用:治疗趋势及预后预测因素
Adv Radiat Oncol. 2019 Aug 8;5(1):85-91. doi: 10.1016/j.adro.2019.07.018. eCollection 2020 Jan-Feb.
3
Ultrasound-Guided Percutaneous Thermal Ablation of Renal Cancers-In Search for the Ideal Tumour.
超声引导下经皮热消融治疗肾癌——寻找理想肿瘤
Cancers (Basel). 2023 Jan 14;15(2):518. doi: 10.3390/cancers15020518.
4
Ultrasound-guided thermal ablation versus laparoscopic surgery for focal nodular hyperplasia of the liver: A retrospective controlled study.超声引导下热消融术与腹腔镜手术治疗肝脏局灶性结节性增生的回顾性对照研究
Front Oncol. 2022 Aug 4;12:932889. doi: 10.3389/fonc.2022.932889. eCollection 2022.
Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis.肾部分切除术的肾肿瘤评分的预测价值:系统评价和荟萃分析。
Eur Urol Focus. 2020 May 15;6(3):490-504. doi: 10.1016/j.euf.2019.11.004. Epub 2019 Nov 24.
4
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery.肾细胞癌治疗:来自拉丁美洲泌尿生殖系统合作组和拉丁美洲肾癌组的专家小组建议:聚焦手术治疗
Ther Adv Urol. 2019 Sep 9;11:1756287219872324. doi: 10.1177/1756287219872324. eCollection 2019 Jan-Dec.
5
Association among the R.E.N.A.L. nephrometry score and clinical outcomes in patients with small renal masses treated with percutaneous contrast enhanced ultrasound radiofrequency ablation.经皮对比增强超声引导下射频消融治疗小肾肿瘤患者的R.E.N.A.L.肾计量评分与临床结局的相关性
Cent European J Urol. 2019;72(2):92-99. doi: 10.5173/ceju.2019.1833. Epub 2019 Jun 4.
6
Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2-4 cm: A population-based study.小于2厘米或2 - 4厘米肾细胞癌的冷冻消融、射频消融和部分肾切除术的比较:一项基于人群的研究。
Medicine (Baltimore). 2019 May;98(21):e15610. doi: 10.1097/MD.0000000000015610.
7
RENAL nephrometry score: Predicting perioperative outcomes following open partial nephrectomy.肾计量评分:预测开放性肾部分切除术后的围手术期结局。
Urol Ann. 2019 Apr-Jun;11(2):187-192. doi: 10.4103/UA.UA_93_18.
8
Epidemiology of Renal Cell Carcinoma.肾细胞癌的流行病学。
Eur Urol. 2019 Jan;75(1):74-84. doi: 10.1016/j.eururo.2018.08.036. Epub 2018 Sep 19.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected Outcomes.Ablation 与切除术治疗Ⅰ期肾细胞癌:临床管理和选定结局的国家差异。
Radiology. 2018 Sep;288(3):889-897. doi: 10.1148/radiol.2018172960. Epub 2018 Jul 3.